Sonova Holding AG
SIX:SOON
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
248
335.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CHF.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Sonova Holding AG
Sonova Holding AG
Net Issuance of Common Stock
Sonova Holding AG
Net Issuance of Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sonova Holding AG
SIX:SOON
|
Net Issuance of Common Stock
-CHf41m
|
CAGR 3-Years
49%
|
CAGR 5-Years
36%
|
CAGR 10-Years
-4%
|
|
|
Metall Zug AG
SIX:METN
|
Net Issuance of Common Stock
CHf1.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Medacta Group SA
SIX:MOVE
|
Net Issuance of Common Stock
-€3.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Straumann Holding AG
SIX:STMN
|
Net Issuance of Common Stock
-CHf18.3m
|
CAGR 3-Years
-62%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Medmix Ltd
SIX:MEDX
|
Net Issuance of Common Stock
-CHf3.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Sonova Holding AG
Glance View
In the world of audiological solutions, Sonova Holding AG stands out as a beacon of innovation and influence. Based in Switzerland, this company has carved a niche for itself as a global leader in hearing care solutions. Sonova’s operations span the entire spectrum of the hearing care market, from manufacturing hearing instruments to cochlear implants and advanced wireless communication systems. Their unique value proposition lies in the integration of cutting-edge technology with a deep understanding of consumer needs, which allows them to offer tailored solutions that enhance the lives of the hearing impaired. Through a network of brands, including Phonak and Unitron, Sonova ensures a broad reach and caters to diverse customer segments across different geographies. The strength of Sonova's offerings is underscored by continuous investment in research and development, which helps maintain a competitive edge in innovation-driven product lines. The business model of Sonova integrates design, technology, and service with a steady output of hearing solutions that meet high-quality standards. The company generates revenue primarily from the sales of hearing devices, which include both traditional hearing aids and more technologically advanced options like cochlear implants. Additionally, Sonova benefits from sales of audiological care services, leveraging a global network of audiologists and service points to provide personalized care and support. This combination of product and service sales creates a resilient revenue stream that is further bolstered by the company's strategic acquisitions and partnerships, which expand both its technological resources and its market presence. Through this combination of an expansive product portfolio and a robust service network, Sonova not only secures financial success but also contributes meaningfully to the broader community by addressing one of the most fundamental human needs—communication.
See Also
What is Sonova Holding AG's Net Issuance of Common Stock?
Net Issuance of Common Stock
-41m
CHF
Based on the financial report for Sep 30, 2024, Sonova Holding AG's Net Issuance of Common Stock amounts to -41m CHF.
What is Sonova Holding AG's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 10Y
-4%
Over the last year, the Net Issuance of Common Stock growth was 75%. The average annual Net Issuance of Common Stock growth rates for Sonova Holding AG have been 49% over the past three years , 36% over the past five years , and -4% over the past ten years .
You don't have any saved screeners yet